Zobrazeno 1 - 4
of 4
pro vyhledávání: '"R S Ravshanova"'
Autor:
I V Botezatu, T T Valiev, T E Dushenkina, K V Smirnova, R S Ravshanova, D M Maksimovich, A V Likhtenstein, V E Gurtsevich, A V Popa, N B Senyuta
Publikováno v:
Современная онкология, Vol 20, Iss 1, Pp 23-28 (2018)
Classical Hodgkin's lymphoma (cHL) is one of the many malignant tumors associated with the Epstein-Barr virus (EBV). It is shown that EBV-positive cases of cHL are distributed with different frequencies among all cases of the disease. The frequency o
Externí odkaz:
https://doaj.org/article/a40a19fc5879483a80f722e09ee097b0
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (9)
Large-dose chemotherapy (LDCT) with auto- and allogenic transplantation of blood stem cells (BSC) in pediatric oncology remains so far the last hope for many patients. The number of such procedures made in Europe increases by 10% every year. At the s
Autor:
M Ia, Iankelevich, I S, Dolgopolov, L Iu, Andreeva, R S, Ravshanova, D G, Izhogin, D M, Mkheidze, E V, Ogorodnikova, G L, Mentkevich
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (6)
The authors examined 8 patients with pretreated relapsing or resistant solid tumors (Wilms'--4, rhabdomyosarcoma--3, synovial sarcoma--1) who received 16 courses of chemotherapy: iphosphamide, 1800 mg/m2/day (days 1-5), vepeside, 100 mg/m2/day (days
Publikováno v:
Pediatriia. (11)
To decide the problem of adequacy of preoperative treatment and postoperative special therapy, it is necessary to determine the degree of therapeutic pathomorphosis of primary osteogenic sarcoma. According to the materials of the children's clinic of